141 related articles for article (PubMed ID: 32928617)
1. Quantitative biomarkers to predict response to clozapine treatment using resting EEG data.
Masychev K; Ciprian C; Ravan M; Manimaran A; Deshmukh A
Schizophr Res; 2020 Sep; 223():289-296. PubMed ID: 32928617
[TBL] [Abstract][Full Text] [Related]
2. A Machine Learning Approach Using Effective Connectivity to Predict Response to Clozapine Treatment.
Ciprian C; Masychev K; Ravan M; Reilly JP; Maccrimmon D
IEEE Trans Neural Syst Rehabil Eng; 2020 Dec; 28(12):2598-2607. PubMed ID: 33513093
[TBL] [Abstract][Full Text] [Related]
3. A machine learning approach using auditory odd-ball responses to investigate the effect of Clozapine therapy.
Ravan M; Hasey G; Reilly JP; MacCrimmon D; Khodayari-Rostamabad A
Clin Neurophysiol; 2015 Apr; 126(4):721-30. PubMed ID: 25213349
[TBL] [Abstract][Full Text] [Related]
4. Advanced Signal Processing Methods for Characterization of Schizophrenia.
Masychev K; Ciprian C; Ravan M; Reilly JP; MacCrimmon D
IEEE Trans Biomed Eng; 2021 Apr; 68(4):1123-1130. PubMed ID: 33656984
[TBL] [Abstract][Full Text] [Related]
5. A pilot study to determine whether machine learning methodologies using pre-treatment electroencephalography can predict the symptomatic response to clozapine therapy.
Khodayari-Rostamabad A; Hasey GM; Maccrimmon DJ; Reilly JP; de Bruin H
Clin Neurophysiol; 2010 Dec; 121(12):1998-2006. PubMed ID: 21035741
[TBL] [Abstract][Full Text] [Related]
6. A machine learning approach using P300 responses to investigate effect of clozapine therapy.
Ravan M; MacCrimmon D; Hasey G; Reilly JP; Khodayari-Rostamabad A
Annu Int Conf IEEE Eng Med Biol Soc; 2012; 2012():5911-4. PubMed ID: 23367274
[TBL] [Abstract][Full Text] [Related]
7. Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia.
Semiz UB; Cetin M; Basoglu C; Ebrinc S; Uzun O; Herken H; Balibey H; Algul A; Ates A
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1330-6. PubMed ID: 17618026
[TBL] [Abstract][Full Text] [Related]
8. Modeling Approach with Therapeutic Drug Monitoring Data to Describe Time Course of Clozapine Exposure and Positive and Negative Syndrome Scale Scores.
Park SI; Kim S; Kim MG; Lim HS; Kim E
Ther Drug Monit; 2023 Jun; 45(3):417-424. PubMed ID: 36097334
[TBL] [Abstract][Full Text] [Related]
9. Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: A retrospective 6-month mirror-image study.
Bioque M; Parellada E; García-Rizo C; Amoretti S; Fortea A; Oriolo G; Palau P; Boix-Quintana E; Safont G; Bernardo M
Eur Psychiatry; 2020 Jul; 63(1):e71. PubMed ID: 32669145
[TBL] [Abstract][Full Text] [Related]
10. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G
Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074
[TBL] [Abstract][Full Text] [Related]
11. Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness.
Barnes TR; Leeson VC; Paton C; Marston L; Davies L; Whittaker W; Osborn D; Kumar R; Keown P; Zafar R; Iqbal K; Singh V; Fridrich P; Fitzgerald Z; Bagalkote H; Haddad PM; Husni M; Amos T
Health Technol Assess; 2017 Sep; 21(49):1-56. PubMed ID: 28869006
[TBL] [Abstract][Full Text] [Related]
12. The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: A systematic review.
Shah P; Iwata Y; Plitman E; Brown EE; Caravaggio F; Kim J; Nakajima S; Hahn M; Remington G; Gerretsen P; Graff-Guerrero A
Psychiatry Res; 2018 Oct; 268():114-122. PubMed ID: 30015109
[TBL] [Abstract][Full Text] [Related]
13. Clozapine in patients with chronic schizophrenia: serum level, EEG and memory performance.
Adler G; Grieshaber S; Faude V; Thebaldi B; Dressing H
Pharmacopsychiatry; 2002 Sep; 35(5):190-4. PubMed ID: 12237790
[TBL] [Abstract][Full Text] [Related]
14. ABCB1 and DRD3 polymorphism as a response predicting biomarker and tool for pharmacogenetically guided clozapine dosing in Asian Indian treatment resistant schizophrenia patients.
M N; Patil AN; Pattanaik S; Kaur A; Banerjee D; Grover S
Asian J Psychiatr; 2020 Feb; 48():101918. PubMed ID: 31896438
[TBL] [Abstract][Full Text] [Related]
15. Sleep EEG and spindle characteristics after combination treatment with clozapine in drug-resistant schizophrenia: a pilot study.
Tsekou H; Angelopoulos E; Paparrigopoulos T; Golemati S; Soldatos CR; Papadimitriou GN; Ktonas PY
J Clin Neurophysiol; 2015 Apr; 32(2):159-63. PubMed ID: 25350635
[TBL] [Abstract][Full Text] [Related]
16. The critical treatment window of clozapine in treatment-resistant schizophrenia: Secondary analysis of an observational study.
Yoshimura B; Yada Y; So R; Takaki M; Yamada N
Psychiatry Res; 2017 Apr; 250():65-70. PubMed ID: 28142068
[TBL] [Abstract][Full Text] [Related]
17. The association between clinical, sociodemographic, familial, and environmental factors and treatment resistance in schizophrenia: A machine-learning-based approach.
van Hooijdonk CFM; van der Pluijm M; de Vries BM; Cysouw M; Alizadeh BZ; Simons CJP; van Amelsvoort TAMJ; Booij J; Selten JP; de Haan L; Schirmbeck F; van de Giessen E
Schizophr Res; 2023 Dec; 262():132-141. PubMed ID: 37950936
[TBL] [Abstract][Full Text] [Related]
18. Disorganization domain as a putative predictor of Treatment Resistant Schizophrenia (TRS) diagnosis: A machine learning approach.
Barone A; De Prisco M; Altavilla B; Avagliano C; Balletta R; Buonaguro EF; Ciccarelli M; D'Ambrosio L; Giordano S; Latte G; Matrone M; Milandri F; Francesco DN; Vellucci L; de Bartolomeis A
J Psychiatr Res; 2022 Nov; 155():572-578. PubMed ID: 36206601
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of olanzapine in comparison with clozapine for treatment-resistant schizophrenia: evidence from a systematic review and meta-analyses.
Souza JS; Kayo M; Tassell I; Martins CB; Elkis H
CNS Spectr; 2013 Apr; 18(2):82-9. PubMed ID: 23253621
[TBL] [Abstract][Full Text] [Related]
20. Non-linear dynamic analysis of clozapine-induced electroencephalographic changes in schizophrenic patients--a preliminary study.
Kang UG; Par KT; Ahn YM; Koo YJ; Yoon SC; Yi SH; Kim YS
Prog Neuropsychopharmacol Biol Psychiatry; 2001 Aug; 25(6):1229-39. PubMed ID: 11474842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
